The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Point-Of-Care-Testing (POCT) Market Evolve From 2026 To 2030?

The point-of-care-testing (poct) market size has demonstrated rapid expansion in recent years. It is forecast to grow from $50.79 billion in 2025 to $56.68 billion in 2026, at a compound annual growth rate (CAGR) of 11.6%. The historical growth can be ascribed to a number of factors, including the increasing prevalence of chronic diseases, the growing necessity for quick clinical decision making, the rise in emergency and critical care services, constrained access to centralized laboratories, and the demand for immediate diagnostic findings.

The point-of-care-testing (poct) market size is anticipated to experience substantial growth over the next few years. It is projected to expand to $86.91 billion in 2030, achieving a compound annual growth rate (CAGR) of 11.3%. This expected expansion during the forecast period can be attributed to advancements in poct device miniaturization, the increased prevalence of home care and remote patient monitoring, a rise in infectious disease outbreaks, the progressive decentralization of healthcare, and the growing adoption of self-testing diagnostics. Significant trends within this period include the increasing implementation of rapid diagnostic testing at the point of care, a higher demand for home-based and self-testing solutions, the proliferation of over-the-counter diagnostic products, a strengthened emphasis on early disease detection and screening, and improvements in the accuracy and sensitivity of poct devices.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Point-Of-Care-Testing (POCT) Market?

The expanding utilization of telemedicine is set to propel the growth of the point-of-care-testing (POCT) market going forward. Telemedicine refers to the provision of medical care remotely, employing digital communication technologies such as video calls, phone calls, or secure messaging. The uptake of telemedicine is driven by increasing demand for convenient, timely, and contact-free healthcare services, notably boosted by the COVID-19 pandemic. Point-of-care testing (POCT) supports telemedicine by offering rapid, reliable diagnostic results that can be instantly shared with remote healthcare providers. For instance, in April 2025, data from the American Hospital Association, a US-based professional organization company, showed that in 2023, more than 12.6% of Medicare beneficiaries used telehealth services. By 2036, the number of physicians is projected to reach up to 86,000. Telehealth plays a vital role in helping to alleviate the growing physician shortage. Therefore, the increasing adoption of telemedicine is driving the expansion of the point-of-care-testing (POCT) market.

Which Segment Areas Are Covered In The Point-Of-Care-Testing (POCT) Market Analysis?

The point-of-care-testing (poct) market covered in this report is segmented –

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

What Key Developments And Trends Are Impacting The Point-Of-Care-Testing (POCT) Market?

Leading companies in the point-of-care testing (POCT) market are increasingly emphasizing technological innovations, such as microfluidic rapid antimicrobial-susceptibility testing (AST) systems, to meet the growing demand for quicker, clinic-level diagnostics and improved antimicrobial stewardship in primary care. This microfluidic AST technology utilizes fluid channels at the micrometer scale to culture and identify bacteria from patient samples—like urine—and determine their antibiotic susceptibility in a fraction of the time required by conventional culture-based methods, which can take several days. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, unveiled the PA 100 AST System, a compact POCT analyser that employs Sysmex Astrego’s proprietary microfluidic cartridges to detect bacteria in approximately 15 minutes and deliver complete AST results in about 30 minutes. The system is exceptionally user-friendly: healthcare professionals simply place the sample into a single-use cartridge, insert it into the desktop analyser, and receive automated AST readouts without needing specialized laboratory training. This quick turnaround enables timely antibiotic decisions during the initial patient visit, supporting efforts to reduce inappropriate prescriptions and combat antimicrobial resistance (AMR).

Which Global Companies Are Actively Competing In The Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience

Read the full point-of-care-testing (poct) market report here:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

What Are The Leading Geographic Regions In The Point-Of-Care-Testing (POCT) Market?

North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Point-Of-Care-Testing (POCT) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27391&type=smp

Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2026, By The Business Research Company

Precast Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/precast-construction-global-market-report

Modular And Prefabricated Nonresidential Building Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/modular-and-prefabricated-nonresidential-building-construction-global-market-report

Ready Mix Concrete Market Report 2026

https://www.thebusinessresearchcompany.com/report/ready-mix-concrete-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model